Fifth Third Bancorp

SEC CIK: 0000035527
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

RXRX holding history

Recursion Pharmaceuticals, Inc. in every 13F filed by Fifth Third Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RXRX overview All 13F holders of RXRX Full Q2 2026 holdings

Shares (Q2 2026): 4,540
Value: $16.7K
% of portfolio: <0.1%
Quarters held: 3; Since Q1 2025

Holdings of RXRX by Fifth Third Bancorp, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	4,540	$16.7K	<0.1%	+2,270+100.0%	Added	Holders
Q1 2026	2,270	$6.97K	<0.1%	+2,270	New	Holders
Q2 2025	0	$0	0.0%	−146−100.0%	Sold out	Holders
Q1 2025	146	$772	<0.1%	+146	New	Holders